Global Restless Legs Syndrome Competitive Landscape Professional Research Report 2025
Research Summary
Restless Legs Syndrome (RLS), also known as Willis-Ekbom Disease, is a neurological disorder characterized by an irresistible urge to move the legs, often accompanied by uncomfortable sensations. Individuals with RLS typically experience these sensations when at rest, such as during periods of inactivity or sleep, leading to difficulty falling or staying asleep. The sensations are often described as tingling, crawling, itching, or aching, and the only relief comes from movement. The exact cause of RLS is not fully understood, but it may involve genetic factors, iron deficiency, and alterations in dopamine levels. RLS can significantly impact the quality of life by disrupting sleep patterns and causing daytime fatigue. Treatment options may include lifestyle changes, medications, and addressing underlying conditions contributing to the symptoms.
According to DIResearch's in-depth investigation and research, the global Restless Legs Syndrome market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Restless Legs Syndrome include Boehringer Ingelheim, UCB, Astellas, Arbor Pharmaceuticals, GlaxoSmithKline, Ligand Pharmaceuticals Incorporated, Kyowa Hakko Kirin, axxonis Pharma, Jazz Pharmaceuticals, Omeros Corporation, Manhattan Pharmaceuticals etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Restless Legs Syndrome. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Restless Legs Syndrome market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Restless Legs Syndrome market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Restless Legs Syndrome industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Restless Legs Syndrome Include:
Boehringer Ingelheim
UCB
Astellas
Arbor Pharmaceuticals
GlaxoSmithKline
Ligand Pharmaceuticals Incorporated
Kyowa Hakko Kirin
axxonis Pharma
Jazz Pharmaceuticals
Omeros Corporation
Manhattan Pharmaceuticals
Restless Legs Syndrome Product Segment Include:
Pharmacological Therapy
Non-Pharmacological Therapy
Restless Legs Syndrome Product Application Include:
Below 35 Years Old
From 35 to 50 Years Old
Above 50 Years Old
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Restless Legs Syndrome Industry PESTEL Analysis
Chapter 3: Global Restless Legs Syndrome Industry Porter’s Five Forces Analysis
Chapter 4: Global Restless Legs Syndrome Major Regional Market Size and Forecast Analysis
Chapter 5: Global Restless Legs Syndrome Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Passenger Restless Legs Syndrome Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Restless Legs Syndrome Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Restless Legs Syndrome Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Restless Legs Syndrome Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Restless Legs Syndrome Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Restless Legs Syndrome Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Restless Legs Syndrome Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
- 1 Restless Legs Syndrome Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Restless Legs Syndrome Product by Type
- 1.2.1 Pharmacological Therapy
- 1.2.2 Non-Pharmacological Therapy
- 1.3 Restless Legs Syndrome Product by Application
- 1.3.1 Below 35 Years Old
- 1.3.2 From 35 to 50 Years Old
- 1.3.3 Above 50 Years Old
- 1.4 Global Restless Legs Syndrome Market Size Analysis (2020-2032)
- 1.5 Restless Legs Syndrome Market Development Status and Trends
- 1.5.1 Restless Legs Syndrome Industry Development Status Analysis
- 1.5.2 Restless Legs Syndrome Industry Development Trends Analysis
- 2 Restless Legs Syndrome Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Restless Legs Syndrome Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Restless Legs Syndrome Market Analysis by Regions
- 4.1 Restless Legs Syndrome Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global Restless Legs Syndrome Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global Restless Legs Syndrome Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global Restless Legs Syndrome Revenue Forecast by Region (2026-2032)
- 5 Global Restless Legs Syndrome Market Size by Type and Application
- 5.1 Global Restless Legs Syndrome Market Size by Type (2020-2032)
- 5.2 Global Restless Legs Syndrome Market Size by Application (2020-2032)
- 6 North America
- 6.1 North America Restless Legs Syndrome Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Restless Legs Syndrome Market Size by Type
- 6.4 North America Restless Legs Syndrome Market Size by Application
- 6.5 North America Restless Legs Syndrome Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Restless Legs Syndrome Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Restless Legs Syndrome Market Size by Type
- 7.4 Europe Restless Legs Syndrome Market Size by Application
- 7.5 Europe Restless Legs Syndrome Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Restless Legs Syndrome Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Restless Legs Syndrome Market Size by Type
- 8.4 China Restless Legs Syndrome Market Size by Application
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Restless Legs Syndrome Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Restless Legs Syndrome Market Size by Type
- 9.4 APAC (excl. China) Restless Legs Syndrome Market Size by Application
- 9.5 APAC (excl. China) Restless Legs Syndrome Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America Restless Legs Syndrome Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Restless Legs Syndrome Market Size by Type
- 10.4 Latin America Restless Legs Syndrome Market Size by Application
- 10.5 Latin America Restless Legs Syndrome Market Size by Country
- 10.5.1 Mexico
- 10.5.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Restless Legs Syndrome Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Restless Legs Syndrome Market Size by Type
- 11.4 Middle East & Africa Restless Legs Syndrome Market Size by Application
- 11.5 Middle East & Africa Restless Legs Syndrome Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global Restless Legs Syndrome Market Revenue by Key Manufacturers (2021-2025)
- 12.2 Restless Legs Syndrome Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Restless Legs Syndrome Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Boehringer Ingelheim
- 13.1.1 Boehringer Ingelheim Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Boehringer Ingelheim Restless Legs Syndrome Product Portfolio
- 13.1.3 Boehringer Ingelheim Restless Legs Syndrome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.2 UCB
- 13.2.1 UCB Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 UCB Restless Legs Syndrome Product Portfolio
- 13.2.3 UCB Restless Legs Syndrome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.3 Astellas
- 13.3.1 Astellas Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 Astellas Restless Legs Syndrome Product Portfolio
- 13.3.3 Astellas Restless Legs Syndrome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.4 Arbor Pharmaceuticals
- 13.4.1 Arbor Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 Arbor Pharmaceuticals Restless Legs Syndrome Product Portfolio
- 13.4.3 Arbor Pharmaceuticals Restless Legs Syndrome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.5 GlaxoSmithKline
- 13.5.1 GlaxoSmithKline Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 GlaxoSmithKline Restless Legs Syndrome Product Portfolio
- 13.5.3 GlaxoSmithKline Restless Legs Syndrome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.6 Ligand Pharmaceuticals Incorporated
- 13.6.1 Ligand Pharmaceuticals Incorporated Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 Ligand Pharmaceuticals Incorporated Restless Legs Syndrome Product Portfolio
- 13.6.3 Ligand Pharmaceuticals Incorporated Restless Legs Syndrome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.7 Kyowa Hakko Kirin
- 13.7.1 Kyowa Hakko Kirin Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 Kyowa Hakko Kirin Restless Legs Syndrome Product Portfolio
- 13.7.3 Kyowa Hakko Kirin Restless Legs Syndrome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.8 axxonis Pharma
- 13.8.1 axxonis Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 axxonis Pharma Restless Legs Syndrome Product Portfolio
- 13.8.3 axxonis Pharma Restless Legs Syndrome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.9 Jazz Pharmaceuticals
- 13.9.1 Jazz Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 Jazz Pharmaceuticals Restless Legs Syndrome Product Portfolio
- 13.9.3 Jazz Pharmaceuticals Restless Legs Syndrome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.10 Omeros Corporation
- 13.10.1 Omeros Corporation Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.10.2 Omeros Corporation Restless Legs Syndrome Product Portfolio
- 13.10.3 Omeros Corporation Restless Legs Syndrome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.11 Manhattan Pharmaceuticals
- 13.11.1 Manhattan Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.11.2 Manhattan Pharmaceuticals Restless Legs Syndrome Product Portfolio
- 13.11.3 Manhattan Pharmaceuticals Restless Legs Syndrome Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 Restless Legs Syndrome Industry Chain Analysis
- 14.2 Restless Legs Syndrome Industry Raw Material and Suppliers Analysis
- 14.2.1 Restless Legs Syndrome Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Restless Legs Syndrome Typical Downstream Customers
- 14.4 Restless Legs Syndrome Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook